NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Stereo Biotherapeutics

Stereo Biotherapeutics

Private
MontrealHealthcare & Life Scienceshttps://stereobio.com/

Last Round

Accelerator

Jun 20, 2025

Total Funding Raised

$100,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Stereo Biotherapeutics is a biotechnology company that develops miniaturized, multi-specific soluble T-cell receptor (sTCR) biologics to address antigen heterogeneity in oncology and other diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

drug discoverysoluble T-cell receptorsTCRbiologicsAI drug discoveryprecision medicinemulti-specific biologicsin silico drug designpeptide-MHCpMHConcology therapeuticscomputational biologybiotech platformtherapeutic pipelineAI-native biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stereo Biotherapeutics Comparables

Compare Stereo Biotherapeutics with similar companies based on industry and business-model similarity.

Stereo Biotherapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Engimmune Therapeutics
84%
Yellowstone Biosciences
79%
3T Biosciences
77%

Stereo Biotherapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 20, 2025

Key People

Founding team and executive leadership

Lana Janes

Co-Founder And Senior Vice President, Operations And Innovation, Chief Operating Officer

Founding Team

Allyson Tighe

Chief Executive Officer

Executive Team

Stereo Biotherapeutics Investors

Notable investors and investment history

Stereo Biotherapeutics investors
InvestorRounds
Amplitude VenturesAccelerator
Consortium Québécois sur la découverte du médicamentAccelerator
Merck Digital Sciences StudioAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors increased 75% MoM.

Stereo Biotherapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Stereo Biotherapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Stereo Biotherapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontreal
Employee Range11
Year Founded2024
Last FundingJun 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.